Arbolus Intelligence

NAMSA

namsa.com · Northwoods, United States of America

NAMSA is a contract research organization that provides medical device and in vitro diagnostic manufacturers with preclinical, clinical, and regulatory consulting services to support product development and market approval. The company offers laboratory testing, biocompatibility, toxicology, clinical trial management, and quality/regulatory strategy services to help clients navigate global regulatory requirements. NAMSA generates revenue through fee-based research, testing, and consulting engagements with medical technology companies worldwide.

  • Clinical Trial & Research Software
  • IT Consulting & Implementation
Listed in
Revenue
$350.0M
Employees
1,500
Founded
1967
Headquarters
Northwoods, United States of America

What 11 Arbolus experts think of NAMSA

NPS scores range from 5 to 10 with a concentration of high scores from key influencers and high spenders, reflecting strong satisfaction with NAMSA’s expertise and unified offerings. Renewal intent is positive among large accounts, especially those at advanced implementation stages. Stickiness is highest among customers with ongoing or multi-year project engagements. Qualitative feedback highlights the importance of regulatory expertise, streamlined service delivery, and confidence in NAMSA’s team, while minor concerns exist around cost and service availability. Overall Customer Sentiment: Positive

Who reviewed NAMSA

Total customers 11 11 current · 0 former
Reviews growth +6 in six months
Seniority of respondents
  • C-Suite 73% (8)
  • Director 27% (3)
Other Leader C-Suite NPS 6 Submitted Jul 2026
Operations Leader Director NPS 8 Submitted Jun 2026
Operations Leader Director NPS 10 Will renew Submitted Mar 2026

Employer names and spend open in the full report, along with the other 8 customers.

Everything 11 customers told us about NAMSA.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Open the full report

Sentiment

27 Net Promoter Score, from 11 scored reviews
  • Promoters 5
  • Passives 4
  • Detractors 2

Cumulative NPS by month

+0 over 6 months
  • Feb 8
  • Mar 8
  • Jun 8
  • Jul 8
  • Sep 8
  • Oct 8

Net Promoter Score across 2 reviews, accumulated up to each month. Category median 27 across 2 companies.

Praised

  • Broader Specialized Support
  • AI-Enhanced Service Delivery
  • Agility in Regulatory Environments
  • Integrated Regulatory and Testing Support

Criticised

  • Variable Availability and Turnaround
  • Service Speed Risks
  • Cost Sensitivity
  • Risk of Service Quality Decline

What customers say

Integrated Regulatory and Testing Support
“I find it a major advantage that NAMSA provides regulatory, quality, clinical, and testing support all through one organization, making it much easier to manage projects.”
High Confidence with Regulators
“Their industry experience gives me confidence when dealing with FDA or international regulatory requirements.”
Project Risk Mitigation
“With NAMSA, I achieve better planning, fewer surprises, and greater confidence that our product and documentation will meet regulatory expectations.”

Renewal intent

Plan to renew 88%
  • Will renew 7
  • Undecided 1
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 83% 6 answers
  • Director 100% 2 answers
  • 8.6/10 Average score from customers who will renew
  • 5/10 Average score from undecided customers

Top alternatives

Most weighed by NAMSA customers

Report

Customer Report - Oct 2026 Oct 2026 11 + 1

Other companies in both categories with a customer report.

See all 3,014 Data & Analytics companies →

For people who use NAMSA

Do you use NAMSA at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 11 customers of NAMSA have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.